Keytruda (pembrolizumab) - Merck (MSD)
Keytruda: Data from P3 KEYNOTE-522 trial (NCT03036488) for TNBC in 2019 (Merck (MSD)) - Apr 30, 2019 - Q1 2019 Results: Data from P3 KEYNOTE-355 trial (NCT02819518) for 1L TNBC in 2019 
P3 data
https://s21.q4cdn.com/488056881/files/doc_financials/2019/MRK-Q1-2019-Earnings-Presentation.pdf
 
Apr 30, 2019
 
 
fc5030e4-d021-4367-a4bf-676fdf69d715.png